5-HT1Freceptor agonists: A new treatment
✍
Lars Neeb; Jannis Meents; Uwe Reuter
📂
Article
📅
2010
🏛
Springer-Verlag
🌐
English
⚖ 84 KB
Migraine is a debilitating disorder of the CNS. Although therapeutic options for migraine attacks have tremendously advanced with the development of triptans more than a decade ago, several conditions (such as vascular disease) restrict their use. Moreover, some patients do not respond to triptans a